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ABSTRACT 
Antimicrobial resistance is a major public health problem. In the Egyptian hospitals the problem 
was discovered since 2006; however, seven years ago, this problem drew the attention to be one 
of a major risk factors worldwide and in the Egyptian hospitals as well. International 
organizations, such as World Health Organization (WHO) tried to find different solutions to 
prevent transmission of these communicable diseases from country to another by setting different 
guidelines and standards to be followed by countries. The case is to assess the barriers to 
implementation of objectives and guidelines of WHO in one of the biggest public Egyptian 
hospitals, in order to have enough knowledge and gather information about the current situation 
in Egypt. In order to fulfill these objectives, case study from a large public hospital was 
extensively studied through qualitative research methods including interviews and observational 
studies. Findings of the current research are most relevant to public hospitals which serve a huge 
sector in developing countries. Behavioral factors such as weak managerial support, lack of 
communication between healthcare departments, absent standards and guidelines for diagnosis 
and treatment, and subjective decisions in managing patients’ cases are among the major factors 
contributing to the problem. Non behavioral factors such as inadequate infrastructure and poor 
resources are also existing.  
The results of the research give substantial contribution in understanding and identifying the 
behavioral causes of prevalence of multidrug resistance (MDR) problem in Egypt and shed light 
on the possible solutions.  
Key words: WHO, behavioral aspect, antimicrobial policies, MDR. 
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Chapter One: Introduction 
Antimicrobials are medicines which eliminate different pathogens causing infections, such as 
bacteria, viruses and parasites (Li et al, 2012). The nastiest microorganisms are the bacterial 
infections which are treated by antimicrobials named antibiotics. Other antimicrobials which 
combat viral and parasitic diseases, such as HIV and malaria are named antivirals and anti-
parasitic (World Health Organization, 2016). Since the first discovery of antibiotics, they have 
saved millions of lives; this started 70 years ago (CDC, 2018).  
Antimicrobial resistance (AMR) occurs when pathogens acquire new traits and new genes that 
enable them to prevent the action of antimicrobials (CDC, 2019). Thus, People or animals who 
are infected with resistant pathogens will suffer infections that are not responding to antibiotics. 
Furthermore, the bacteria will be more aggressive; it will survive, and the patients get sicker and 
may die (Tadesse et al, 2017). These resistant pathogens have the ability to transfer from one 
patient to another; moreover, have the ability to transfer the resistance from one bacterium to 
another; thus, the cost of medical care rises, and disease spreads nationally and internationally 
(Santajit, 2016- Huddleston, 2014). AMR is on the rise and currently responsible for more than 
700,000 deaths per year worldwide (Roca et al, 2015).  According to the World Bank 2017 
(http://www.worldbank.org/en/topic/health/publication/drug-resistant-infections-a-threat-to-our-
economic-future), if no strong measures are taken to prevent the progress, AMR will cost 
approximately 10 million lives by 2050 worldwide in addition to about US$100 trillion per year 
extra expenses which is more than cancer and diabetes burden combined (Scarafile, 2016). 
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1.1 Antimicrobial resistance is a global problem 
AMR is a global problem which require to apply the concept of “one health”; every country 
irrespective of its level of income and development should be concerned about the problem as 
resistant pathogens do not respect borders (Exner, 2017; WHO, 2016). 
In recent decades, it is estimated that with every misuse of the antimicrobials either in the dosing, 
frequency or timing, antimicrobial drugs are rapidly losing their effectiveness in both developing 
and developed countries, and this foster the opportunity for AMR to flourish (Sefton, 2002). 
However, rigorous management can limit the risks. As a result, people may face a reversal of the 
public-health gains of the past century, and the economic growth if this trend continues (Allen, 
2014). To contain the problem globally and nationally, the world health organization (WHO) set global 
action plan (GAP) in 2015 with definite goals to be followed by countries. Each country should set its 
strategic actions to fulfill the goals and ensure sustainability of actions (Mendelson et al, 2016). 
1.2 RESEARCH OBJECTIVES 
 This research is intended to investigate the current behaviors and actions done by healthcare 
workers which affect antimicrobial resistance and barriers to implementation of the global 
action plan (GAP) in public hospitals in Egypt. Another aspect of the research is to understand 
whether healthcare workers in Egypt are aware of the problem and of WHO international plans 
for AMR. The research also will try to reach some characteristics of the needed reform and the 
impeding factors. 
1.3 Conceptual framework: 
A conceptual framework definition is a chain of linked concepts which when analyzed it 
offers the procedure required to build the frameworks based on the grounded theory 
method (Jabareen, 2009). Analysis of conceptual framework has many benefits including 
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its flexibility, capacity to modify and understanding instead of predicating (Jabareen, 
2008). 
Conceptual frameworks analysis offers the knowledge of know-how and plays 
fundamental epistemological role to understand the difference between beliefs and facts. It 
also explains the knowledge of the way things are in real existence. (Finney & Corbett, 
2007).  
Despite the importance and relation of pharmaceuticals with social and political science, 
there has been a noticeable lack of input of social sciences in setting polices on how to use 
the pharmaceuticals (Smith, 2015). This engagement represents the effective mean to 
address the problem of AMR and to contain the risks of the problem (Cabral, 2015). 
There is great trend to learn from the considerable work of social sciences, so as to provide 
a collective and broader conceptual map through which effective strategies to tackle AMR 
could be created (Cleary, 2016). 
In this thesis the conceptual framework can be perceived by dividing the sectors of the 
problem to private clinics which are managed by owners and depends on dispensing 
antibiotics from pharmacies and pharmacies which are responsible for dispensing 
antibiotics to the community. The second section is the public hospitals which are managed 
by the government and its related departments including infection control and stewardship 
departments. The two sectors are under the umbrella and existing in the community and are 
affecting each other. This research will tackle the public hospitals part as it serves huge 
sector in the community. 
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Figure 1: Conceptual framework (WHO, 2006). 
 
 
 
 
1.4 RESEARCH QUESTIONS: 
Based on the previous objectives, the research questions which are proposed could be formulated 
as follows:  
 To what extent the WHO international policies of AMR are implemented in the 
Egyptian hospitals? This question will examine the process, tools, monitoring and 
evaluation used by healthcare workers to apply the standards of WHO.  
 Are health care workers aware of the problem? This question will give an idea about 
the importance of the issue to healthcare workers. 
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 Are health care workers aware of the WHO policy for AMR? This will give an idea 
about the effectiveness of WHO in local community and whether health care workers 
know the WHO or not. 
 What prevent them from implementing the policy? This question will help to 
understand the different barriers in different communities especially the behavioral 
barriers.  
1.5 Research outline 
The present research is divided into five chapters. The first chapter contains the 
introduction which gives a glance about the problem of antimicrobial resistance worldwide, role 
of international organizations and countries to contain the problem. Research objectives, research 
questions and conceptual framework are also presented in the introduction. Chapter two is the 
literature review which tackles the problem and its health, economical and developmental 
consequences; in addition, a detailed history of the emergence of the problem in Egypt starting 
1999 till now and the actions that were taken in Egypt till now. The different qualitative 
methodologies and SWOT analysis are clearly discussed in the third chapter. Chapter four gives 
an analysis to the findings and discussion of the research. Finally, chapter five provides the 
conclusion and recommendations of the study.  
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Chapter Two: Literature Review  
The literature review will cover the following six points in details 
 The problem of Antimicrobial resistance 
 The history of the problem 
 The extent of the problem 
 The consequences of Antimicrobial resistance on countries 
  The status of Antimicrobial resistance in Egypt 
 What should be done to face the problem? 
 How the crisis is currently handled.  
 The gap in the research that we will fulfill 
2.1The problem of Antimicrobial resistance.  
Antimicrobial resistance crises (AMR) is a grave threat to economy and health (Shrestha, 2018). 
The excessive and faulty usage of antimicrobials in plants, animals, and human being, lead to 
evolution of bacteria which is more aggressive and resistant. This phenomenon occurred 
naturally from the continuous pressure of antibiotics (Shrestha, 2018).  
Those infectious diseases become resistant to any known anti-microbial agent; moreover, they 
are increasing in frequency and scope which will lead to detrimental consequences for the public 
health (Marshall & Levy, 2011). This major crises was shaped by three main factors: the first one 
is the fact that the bacteria are always changing evolutionary with different AMR phenotypes due 
to the wide use of antibiotics (Spellberg et al, 2008) The second cause is that the world now has 
no borders and the microbe can transfer from one community to another easily; the third and last 
factor is the irrational and extensive use of antibiotics especially in developing countries where 
there are no rules undermine over the counter consumption of antibiotics (Holmes et al, 2016).; 
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thus, this antibiotic selective pressure will eventually improve the evolution of bugs to AMR 
ones. Some of these factors are amendable, others are not (Holmes et al, 2016). The fact that the 
world become interconnected and open for all human being cannot be changed, but rules and 
regulations can be put in place to reduce and prevent the evolution of bacteria by setting the 
legislations and change behaviors for the rational use of antimicrobials in addition to extensive 
education program to teach common people and healthcare workers (Michael, 2014). 
Projections and speculations suggest that AMR will be a cause of public health crisis and 
economic inequality globally which will mostly affect low and middle-income countries where 
the burden of AMR is highest (Lim et al, 2016). 
2.2 The history of the problem 
Discovery of penicillin, the first antibiotic in the world, by Sir Alexander Fleming in 1928 is 
considered the start of modern era of antibiotics (Sengupta et al, 2013). Penicillin transformed 
the modern medicine and saved millions of people worldwide (Gould & Bal, 2013). 
In 1940 antibiotics were prescribed for the first time to treat serious bacterial infections, and in 
World War II Penicillin controlled serious bacterial infections among soldiers (Sengupta et al, 
2013). However, shortly after introduction of penicillin in the market, penicillin resistance 
became a huge clinical problem, and by 1950s resistance to penicillin became almost 100% 
(Spellberg &Gilbert, 2014). In response, new antibiotics were discovered and developed by 
pharmaceutical companies; however, the first case of resistance to the new antibiotics was 
identified during that same decade, in 1962 in the United Kingdom and in 1968 in the United 
States. Afterwards, resistance has been seen to nearly all antibiotics that have been designed and 
developed by pharmaceutical companies (Ventola, 2015).  
 
 
15 
 
Figure 2: Antibiotic discovery and resistance timeline (Bush et al, 2011). 
 
2.3 The extent of the problem 
The problem of AMR is affecting three sectors: animals, plants, and human beings (Cabello, 
2006); however, the scope of this thesis is AMR in human beings in hospitals.  
On the side of human being, AMR has dramatic consequences on health; however, the indirect 
impact of antimicrobial resistance  are beyond health risks; for example, it has a negative effect 
on development; in addition, it is a drain on economy with many economic losses due to reduced 
productivity caused by sickness (of both human beings and animals) and higher costs of 
treatment (Regea, 2018). 
 
2.3.1 Effect on health 
Antibiotic resistance problem is rising dangerously worldwide, bacteria are acquiring new 
resistance mechanisms and have the ability to transfer from one place to another and spread all 
around the globe. Infections such as pneumonia, tuberculosis are becoming difficult to treat and 
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sometimes impossible to treat because antibiotics become not effective. The problem grows 
especially in the countries where purchasing of antibiotics is easily made over the counter and 
there is over prescription by health workers and over usage by the public (WHO, 2019)  
For example in the United States of America, it was estimated that around 50.9 % of bacteria 
causing surgical site infections are multidrug resistant (Li & Webster, 2018).  
In another example according to WHO report which gather information from 22 countries, the 
proportion of patients who have blood stream infections due to resistant bacteria ranged within 
countries from zero to 82% depending on application of the standards of antibiotic usage. (WHO, 
2018). 
2.3.2 The status of Antimicrobial resistance in Egypt 
Egypt is one of the low and middle-income countries (LMIC) where data regarding endemic 
antimicrobial resistance are sparse, especially because over-the-counter antibiotic use is common 
(Abegunde, 2007). Data from resource rich settings and hospitals is generally better compared to 
that in the community and resource limited settings (Ayukekbong, 2017). The striking findings 
about AMR have been recently detected in Egypt; the prevalence of AMR is almost 90% of the 
bacteria circulating hospitals. 
The information in Egypt is sparse; however, the current data is alarming. According to a study 
done to assess the resistant microbes in five hospitals in Egypt from 1999-2000, high rate of 
microbial resistance was detected, 70% of gram positive infections were resistant. Resistance 
among gram negative bacteria is higher, resistance ranges from 94% , 62% and 48% according to 
the type of antibiotic which called at that time urgently for nationwide surveillance to monitor 
these patterns in Egypt (El Kholy et al, 2003). 
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This was followed by another study in 2006 to assess the rate of resistance by active surveillance 
in three big university hospitals ICUs in Egypt from 2006-2007. 600 isolates were detected from 
which around 80% were resistant in gram negative bacteria and 60% resistance in gram positive 
bacteria. Again this highlights the urgent need for actions to augment infection prevention and 
control and setting the standards to be strictly followed (Saied et al, 2011). 
Another study was done to study the microbiological profiles, and investigate the increasing rate 
of mortality in intensive care units in three hospitals in Cairo University only. Between 2009 and 
2010, the study revealed high level of antimicrobial resistance in different gram negative bacteria 
ranging from 85% to 76% of resistance which differ according to the type of bacteria isolated 
(El-kholy et al, 2012). 
In 2013 there was a trial to develop a surveillance system in Egypt and a study was published 
from a joint project between the Egyptian ministry of health and center of disease and control  
(USA) stated that, from twenty eight hospitals with 91 ICUs were investigated for the prevalence 
of multidrug resistant bacteria, the percent of resistance ranged from 92.8 to 54% according to 
the type of bacteria. The paper also called again for urgent sustainability of the surveillance 
system and enhancing infection prevention and control to contain the problem (Talaat et al, 
2016). 
2.3.3. Health system barriers in Egypt 
Egypt has a huge issue in the fragmentation of the Egyptian healthcare system which make 
setting the standards and implementation is hard. There are different providers and different 
financing agents either public, private, NGOs or public private partnership (Haley & Bég, 2012). 
These different agencies are managing the healthcare sector under various authorities in the 
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government with different laws and levels of independence (Muleady-Mecham et al, 2009) 
which make controlling people’s behavior, monitoring and evaluation extremely difficult This is 
an alarming level of bacterial resistance which highlight the fact that widespread antimicrobial 
resistance exists in Egypt and need immediate interventions (Gladstone, 2017). 
Due to this Egypt embraces the WHO global action plan to develop the national action plan to 
combat antimicrobial resistance in Egypt. This Global action plan was approved by all member 
states. The WHO plan adopts the one health concept which states that people’s health is 
connected to animals’ health and plants’ health, it is a collaborative approach at the regional, 
national and global level for better health outcome for all (CDC, 2018). 
 
2.3.4 Effect on development: 
AMR will hamper and impede the implementation of the Sustainable Development Goals 2030 
(WorldBank, 2017).  In contrary to the SDG 1 ,which states that no poverty, AMR will be 
driving around 24 million people into extreme poverty (Cecchini, 2015) and potentially resulting 
in millions of deaths which is also against SDG 3” Good health and wellbeing” (Barredo, 2015) 
Moreover, it will result in increasing inequality which is against SDG10. Sustainable 
development goals are strongly interconnected with the containment of AMR; thus, failure or 
loose actions towards AMR would definitely make these SDGs less likely to be achieved (World 
bank, 2017). 
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2.3.5 A Threat to the Global Economy 
The worldBank has made a simulation to the spread of AMR from now to 2050 to quantify the 
global losses, and attract the policy makers and draw their attention towards the problem 
(Shrestha et al, 2018). Two scenarios were set; one scenario with low AMR burden, and another 
scenario with high AMR impact. The models and scenarios were based on the economic effect 
on the labor supply and livestock productivity (O’Neill, 2015) 
In the scenario of low AMR impacts, the simulations found that, by 2050, there will be a decline 
in the annual global gross domestic product GDP by 1.1 percent, relative to a base-case with no 
AMR effects; the decline would exceed one trillion dollars annually after 2030. In the other 
scenario with high AMR-impact, the loss worldwide will be 3.8 percent of its annual GDP by 
2050, with an annual loss of $3.4 trillion by 2030 (World bank, 2017). 
By comparing the losses due to AMR in the period through 2050 and the losses due to global 
financial crises, we found that the reduction in global GDP caused by AMR will be equal to the 
losses provoked by the financial crisis, at their most severe (Van Boeckel et al, 2015).  However, 
the impact of AMR is worse because the repercussion would be felt during the entire period until 
2050, not just for a couple of years, as was the case in the acute phase of the financial crises 
which has occurred recently (Michael, 2014- Friedman, 2016). The economic inequality between 
countries would increase (Levy, 2001), and this would happen because low and middle- income 
countries (LMIC) would experience larger drops in economic growth than wealthy countries. 
Low and middle income countries will have higher prevalence of AMR and greater dependence 
on labor incomes (Singer, 2016), and most of the burden would occurs in low-income countries. 
With increasing the disease burden by 2050 and rising the AMR, the healthcare expenditure, 
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both public and private, will exceed 25% in low income countries, where the prevalence of AMR 
is highest, and 15% in middle and 6% in high income countries (Economou, 2015). 
 
2.4 Protecting a Global Public Good 
Containment of AMR is considered to be protecting a global public good. This is because all 
countries can enjoy the benefits of successful AMR containment; on the other hand, all countries 
will be harmed if AMR is remained without being curbed and controlled (Saleh et al, 2015).  
This responsibility is held on public authorities, especially national governments, in protecting 
this good and prevent spread of pathogens, including drug-resistant strains (IDSA, 2011). 
The loss of efficacy of antibiotics and other antimicrobials worldwide can be understood as a 
common goods curse (Holmes et al, 2016).  The problem of commons occurs when people in a 
community waste a limited, shared resource, as each one pursues own self-interest by exploiting 
the resource for private benefit. No one wants the common resource to be exhausted. However, 
the group’s behavior leads to precisely this result. This was the same case as in the collapse of 
fisheries due to overfishing, for example. The overuse and misuse of antimicrobial drugs 
worldwide show a similar pattern (World Bank, 2017). 
2.5 The role of stakeholders in the control of antimicrobial resistance 
There is no sole institution responsible for controlling antimicrobial resistance. The 
responsibility is shared between healthcare providers and others (Silbergeld, 2008) However, 
continuous education is mandatory for physicians and scientists to be aware and learn the 
importance of evidence based and good prescription practices. Other stake holders who include 
general population and government also play a fundamental role. Governments ought to put this 
issue as a priority and a public concern. Polices and regulation should be set and enforced in their 
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implementation; in addition, monitoring and evaluation of these implementations should be done 
to ensure that policies are applied effectively (Blakely et al, 2006).  
The population on the other hand was perceived by researchers as a vital sector who needs to be 
educated on the threat of Antimicrobial resistance. The role of Media professionals appeared to 
be the link to convey this message to the population and consequently they require adequate 
training on conveying scientific and medical information in simple language (Eysenbach, 2008). 
Other researchers stated the importance of using multiple channels to learn population about the 
consequences and unsafe practices that increase the emergence of multidrug resistant bugs and 
recommended this as another important approach. This approach had shown success when used 
with journalisms to fight HIV/AIDS in developing countries, and many policy makers are 
expecting that it will be effective also in Antimicrobial resistance. There are a number of 
initiatives have been done to fight AMR by the governments in developed countries but these 
initiative are still limited in developing countries due to financial stress and limitation of the 
resources (Ayukekbong et al, 2017).   
Currently, the international health care bodies acknowledged the importance of the critical 
situation of antimicrobial resistance crises and its effect on the human nature (Kuehn, 2013). 
These bodies are concerned with solving the problem and managing the crises. They 
provided a number of regulations and recommendations which could lead to actions taken by 
governments to address this serious issue. Indeed, these recommendations lead to programs 
and chain of actions in a trial to contain the problem; the actions fall in two categories: either 
prevention or control (Hidron, et al, 2008). The idea is that with prevention, the need for 
antimicrobials will be limited because the problem will be prevented from the start. With 
control they aim to provide new antibiotics which are more effective than the currently used 
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antimicrobials. In conclusion the measures that were taken aimed to prevention through 
controlling the bugs, vaccination, and educating public and clinicians about the standards of 
antimicrobial usage (Laxminarayan et al, 2013). Governmental legislations are mandatory to 
emphasize the implementation of policies (Harmsen et al, 2013).  All the initiatives which 
were taken by the international bodies had proved success; however in this problem, the 
frequency by which the infectious bugs are evolved and propagated in the communities gives 
an alarm that these actions need to be expanded and more actions are needed to be added to 
contain the problem. (World Health Organization, 2012). 
2.6 The gap in the research that the thesis will fulfill 
The causes which lead to prevalence of antimicrobial resistance differ from one country to 
another.  In developing countries, root causes are more complex from developed ones. Most of 
the current research about antimicrobial resistance is targeting the resource limitedness and lack 
of infrastructure in the developing countries (Aslam et al, 2018). Other researches are looking for 
new antibiotics to kill the microbes and urge the pharmaceutical companies to design new 
antibiotics in the pipeline (Li& Webster, 2018). The current Research lack the behavioral aspect 
of healthcare practitioners and patients’ in using antimicrobials. These factors include inadequate 
prescription of antibiotics, inadequate patient and clinician’s education, and lack of experienced 
personnel and presence of antibiotics on the counter to be sold without prescription. Thus, the 
intervention efforts should be home-planned and based on the factors prevalent in the developing 
countries to meet the needs of this part of the world. These root causes if managed could be and 
its importance as it could be an easy and effective solution in controlling the risk of antimicrobial 
resistance and this will be assessed by this thesis. Taking the interventions in the developed 
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countries as a guide will be beneficial; however, we cannot depend on them blindly and must 
take the situation of developing countries into consideration (Podolsky et al, 2015).  
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Chapter Three: Research Methodology 
3.1 Design 
 The research question is to detect the extent of implementation of WHO international policies 
for antimicrobial resistance in the Egyptian hospitals, and to reach our target we used 
qualitative research methodologies. The qualitative method aims to gather in-depth 
understanding of social behavior and the reasons that govern such behavior (Yilmaz, 2013). As 
this problem is considered to be a collective social behavior, data gathering will depend mainly 
on qualitative research methods. The methods will focus on meanings, views, and perceptions, 
where participants’ description of the situation will be highly valued. Multiple methods of 
qualitative research will be used including in-depth interviews and participant observation. This 
variation is valuable as it will allow triangulation and ensure validity and reliability of data. 
3.2 Methodology 
The interviews were designed to be semi-structured based on flexible structure with many 
open ended questions to explore the issue broadly. This was followed by in depth questions to 
study certain issues in details, such as the training and policies physicians use to contain the 
problem of antimicrobial resistance. In addition, further questions were designed based on 
what the interviewee have said to obtain more clarification and details (Britten,1995). 
The following table gives a descriptive data about the interviewees, their positions, years of 
experience, the educational background and the working sector. Interviewing physicians from 
different backgrounds, working sectors and positions was mandatory to collect a clear view 
about the situation. 
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Table 1: Data about the participants to the interviews. 
Code Status  Years of 
experience 
Educational 
background 
Working 
sector 
01 Representative from the 
hospital administrative council 
>20 Laboratory 
consultant 
Public 
hospital 
02 Department head in 
international health 
organization 
>20 Laboratory 
consultant 
International 
organization 
03 Chest physician 7 Specialist 
physician 
Public 
hospital 
04 ICU physician 15 Consultant 
Physician 
Public 
hospital  
05 Internal medicine  5 Resident 
Physician 
Public 
Hospital 
06 Surgical nurse 6 Nurse Public 
hospital 
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07 Lab consultant 10 Clinical 
microbiology lab 
Public 
hospital 
08 Lab specialist 8 Clinical 
microbiology lab 
Public 
hospital 
09 Infection control practitioner  3 Infection control 
doctor 
Public 
hospital 
10 Infection control practitioner  4 Infection control 
doctor 
Public 
hospital 
11 Pharmacist 8 Pharmacist  Public 
hospital 
Moreover, Observational method was used to systematically observe and watches people in 
their normal settings and working environment thus it was an effective way to find out 
people’s behaviors and actions in their working places (Pope et al, 2000). This way was 
important because it required going to the field and studying the whole situation followed by 
describing and analyzing the field. In health care settings this method has been proved to be 
profound and descriptive (Mays & Pope, 1995). 
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Table 2. Schedule of observational study 
Day/ February Observational site 
Saturday / 2nd  The infection control  
Sunday/ 3rd  The microbiology lab 
Monday/ 4th  The inpatient pharmacy 
Tuesday/ 5th  The ICU  
Wednesday/ 6th  The surgical department. 
Thursday/ 7th  The chest department, The internal medicine 
department 
Friday/ 8th  The obstetrics and gynecological department 
 
SWOT analysis was added as a tool to identify core strengths, weaknesses, opportunities, and 
threats lead to evaluate recommendations and new ideas to solve the problem (Van 
Wijngaarden, et al, 2012). 
3.3 Sampling 
 Purposive sampling strategy will be pursued in choosing the participants; preliminary criteria 
relevant to the research objectives will be predetermined to guide the selection process 
(Guetterman, 2015). The selection criteria are as following: all participants who are working in 
the medical field and have direct or indirect effect on the rate of AMR in the hospital; in 
addition, all stakeholder which includes representatives from the WHO will be interviewed. 
Interviews are an effective qualitative method for getting participants to discuss their personal 
encounters, opinions, and experiences (Alshenqeeti, 2014). In turn, eleven interviews will be 
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conducted and intended to include participants from different medicinal fields. 
Interviews questions are designed to elicit a vivid picture of the participant’s perspective on 
the problem and the current status of AMR. The questions are prospectively semi structured to 
let interviewees talk freely, and probing questions will be asked if the discussion skewed to 
unneeded direction. 
 All interviews are conducted in Arabic, then translated and transcribed in English by the 
researcher. Before conducting the interviews, all participants will be informed about the 
nature, purpose and possible outcomes of the research through the written informed consent. 
The interviews handouts will be kept confidential and the data will be analyzed and interpreted 
by the researcher.  
3.4 Limitations 
Limitations in the interviews: The size of the sample is limited to the number of the interviewees, 
and also limited to the area in which the interviews are expert in. The quality of the interview 
depends mainly on the respondents; in addition, the response may be subjective. We will not be 
able to meet and interview patients to assess the situation from their view. 
Limitations of observational study: Many behaviors are not open for observation and also cannot 
be quantified by observational techniques. Moreover, observational study is subjective and needs 
experience from the observer to avoid personal bias or pre-conceptions which could kill the 
objectivity in research. 
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3.5 Ethical considerations 
All interviews and observational study were held in the period between January and 
February 2019, after the IRB approval (Annex 12). The interviews were done in Arabic 
language then translated by myself. Before the interview, all interviewees were informed 
about the research and outcome and signed the informed consent (Annex 13).   All 
handouts were kept confidential, and the data was interpreted and analyzed by myself. 
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Chapter Four: Findings and Discussion 
Interviews are effective qualitative methods for allowing participants to discuss their 
opinions, and experiences (Mack et al, 2005). In turn, eleven in-depth interviews were conducted 
with personnel who are involved in dealing with patients and prescribing antibiotics. The 
interviewed participants were of different specialties and ages; they were physicians from chest, 
ICU and internal medicine department, deputy dean for environmental issues, infection prevention 
practitioners, Lab specialists, pharmacists and nurses and the head of communicable diseases in 
WHO Regional Office for the Eastern Mediterranean EMRO. Most of interviewees aged from 25 
to 35, and some of them aged 45 to 60 (table 1). Moreover, observational study was done during 
the regular working days with nurses and physicians, Lab specialists and the pharmacy. This 
variation was extremely important because it helped triangulation and ensured validity and 
reliability of data.  
4.1 Interviews themes and discussion 
The first interview was conducted with the vice dean of the hospital for environment issues, 
she joined the organization since she was resident; this was 23 years ago and she was promoted 
during her career until she reached this position. She knows every aspect in the hospital and what 
was surprising that she knows most of the problems facing the institute from the infection 
prevention and control issues and she knows the ideal solutions, but the solutions are difficult to 
be implemented on the ground due to many reasons; one of them is financial issues. The interview 
was in her office. It seems that the decision is centralized and she had to look into every matter in 
details by herself and give a decision in every single aspect. There is no delegation or 
decentralization of tasks (Annex 1). 
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The second interview was with a department head in international health organization 
concerned by the problem of MDR in Egypt. She was pessimistic about the situation in Egypt. She 
praised infection control department in Alexandria University. However, she mentioned that jobs, 
such as infection control, stewardship of antibiotics in most places in Egypt are part time jobs but 
these jobs require full-time. In addition, people are not compliant and there are no strict rules to 
follow. She stated that the national action plan had been released to fight multidrug resistant 
bacteria, but it is not for public yet and will not be found on the Internet.  She stated that the 
International organizations, such as Center of Disease and Control (CDC) and World Health 
Organization (WHO) are not funding agencies, and they are only agencies for consultation and 
gives advice to nations. The government in Egypt has to set its own policies and the way they are 
going to implement, monitor and evaluate and in her opinion, we are still there and away from 
stated goals. 
  Another interview was with an assistant lecturer (a position after completing residency 
and had master’s degree in the specialty) and the one responsible in the chest department. Residents 
and assistant lectures are the ones who are doing almost all the work in the wards, they are making 
rounds to assess the cases of patients, prescribe antibiotics and following up the patients. The 
interview took place in the ward with a lot of noise and interruption either by the patients or the 
nurses. The physician looked very busy and exhausted; in addition, he knew nothing about the 
antibiotic policy, he was only exposed to some concepts of the infection prevention and control 
during his residency. The physician knows that the problem is huge and there are many MDR in 
the hospital, but do not know how to improve and they are dealing with the situation to isolate 
patients if they have a space for isolation. He do not know anything about the global action plan 
of the WHO (Annex 3). 
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 The fourth interview was with Lecturer in the intensive care unit (ICU); this was a mid-
senior staff dealing patients, most of them harbor multidrug resistance bacteria. The physician 
know that the problem is big and around 70% of patients capture these kinds of bacteria die not 
from the original disease but from the bacterial infection which is not responding to antibiotics. 
The interview was in the office, and there were many interruptions from nurses and junior doctors 
who were asking for consultations. Junior doctors were always asking about prescribing antibiotics 
and the doses required. Nurses were asking for supplies which are not sufficient and want to 
purchase more supplies from donation money. The physician do not have antibiotic policy but he 
tried to teach himself about antibiotics. He had never received training about infection control, yet 
he finds it important and crucial for safe environment. He is looking forward to have a program to 
train junior physicians, but he do not know anything about the initiative of WHO (Annex 4). 
 The fifth interview was with a resident in internal medicine department. The office of the 
residents was very missy and crowded with around five residents in a same small room. The 
resident had a night shift the day before and he supposed to work for the next 24 hours also. He 
was very tired and was giving short answers and seemed not to be interested. The resident knows 
the problem is increasing and getting difficult to have quick fixes. The department develop its own 
internal antibiotic policy and they are following. They do not receive any general antibiotic policies 
from the hospital and he did not receive any training. In addition, he does not know about the 
WHO initiative and global action plan. The decision to isolate the patient or not is very subjective 
i.e some physicians isolate if the patient has MDR infections, others not (Annex 5). 
There were two interviews with infection control practitioners, one responsible for the 
orthopedic department and the other is responsible for the intensive care units in the hospital.  The 
meeting was in their offices where the interview was very friendly. The place was quite with little 
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interruption. One of them was more knowledgeable than the other, both were the same age mid 
seniors, just completed their doctorate degree, they were active and responsible and want to 
improve the infection control situation in the hospital. They both declare that MDR is a huge 
problem in the hospital and everywhere in Egypt. The infection control guidelines are written and 
updated by Ministry of health every 4 years, which is not enough to cope with the rapid change in 
the epidemiology of bugs. They stated that implementing and monitoring the policies is a very 
difficult part. The policies are not distributed to all physicians and nurses, they are only with 
infection control committee. Implementing policies needs training first followed by continuous 
monitoring and evaluation by monitoring tools such as infection rate and surveillance. There are 
different ways to ensure compliance of people either praise or punish but most of the time punish 
works better and this is sad. We try to monitor the infection rate by the surveillance but I find the 
infection is rising. Infection control is a part time job and without resources it means that no 
infection control policies could be applied effectively on ground. They stated that the main factors 
increasing the infection rate and level of MDR resistance is the misuse of antibiotics by physicians. 
The infection control practitioners are working hard with the limited resources they have, they do 
not know about the initiative of WHO global action plan; however, they are applying their own 
objectives which by the way the same as of the WHO objectives (Annex 6, Annex 7). 
 Two interviews were conducted with Laboratory consultant and laboratory specialist in 
the lab. The lab was busy with many technicians and physicians, many times patients or nurses 
come into the laboratory to ask about the results and interpretation or availability of clinical tests. 
There was high interruption but the lab doctors were very cooperative. They stated that MDR is a 
huge problem affecting the whole world, they do not know the GAP initiative but they know that 
there should be a national plan to contain the problem of antimicrobial resistance otherwise the 
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situation will be critical. They are doing the antibiogram to trace the change in the behavior of the 
bacteria every 6 months but they are doing this on demand i.e if any ward want to know its 
antibiogram they make it otherwise it is not part of their routine work. There is no connection 
between the Lab and the pharmacy which means that the lab may be testing for the sensitivity of 
certain antibiotics and these antibiotics are not available for dispensing in the pharmacy and vice 
versa may be the pharmacy has different types of antibiotics but the lab is not testing them in the 
sensitivity thus they are not reported in the sensitivity report and the physician won’t know about 
these antibiotics to dispense them for the patients. In addition, there is no communication between 
the lab personnel and the physicians to consult about cases and their management. Physicians are 
so busy and Laboratory doctors as well; moreover, there is no intranet or working internal phones 
in the wards for communication. The lab request missed many important data about the patient’s 
case and diagnosis which make the interpretation of data from the lab defective and call for urgent 
communication with physicians. From the lab opinion, surgical wards and operating rooms are the 
highest wards with infections and managing these wards means that we managed almost 60% of 
the problem. The major cause of the problem is the misuse of antibiotics either it is empirical 
antibiotics or wrong dosage or wrong duration because most of physicians do not know anything 
about antibiotics and its right usage (Annex 8, Annex9). 
  The tenth interview was with a nurse from the surgical department. This is a senior nurse 
who is working for 24 years in the surgical department. The interview was on the counter of nurses 
in the ward were the files of patients and medications to be administered. This was the night shift 
from 8 pm to 8 am, it was somehow quite comparative to the morning shift. The nurse was cautious 
at the beginning because she did not understand the meaning of the interview, but after a while she 
became at ease and friendly and started to say all the negatives in the ward because she wanted to 
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improve and asked me to try to send her suggestions to the dean. She stated that the problem of 
MDR is a huge problem and it was taken lightly in the beginning until one of her friends caught 
chest infection with MDR bacteria and she was treated for almost 6 months until she recovered 
with remaining complications. She found the infection control policies important. But cannot be 
implemented in these crowded and busy hospitals where the infrastructure is not compatible with 
infection control policies. The patients are sitting side by side and the number of nurses is very 
defective. They do not have the infection control policies in hand it is only with infection control 
nurses, and they are receiving infection control training may be once a year. The measures they 
usually take to prevent transmission of MDR is isolation but this is not available all the time 
because of the limited places and the decision depends on the physician, thus it is subjective 
decisions. She did not hear about the initiative of the GAP WHO before but she found the 
objectives of the global action plan important and feasible for application (Annex 10). 
  The last interview was with a pharmacist in the main pharmacy of the hospital. There are 
many branches for this pharmacy, two internal pharmacies in each hospital for the inpatients and 
one in each hospital for the outpatients. The concept of clinical pharmacy is still new in this 
hospital and there is huge resistance form the physicians to allow the pharmacist to prescribe the 
antibiotics, adjust doses and decide the frequency of therapy. The pharmacist is in mid-senior age 
and she confirms that the problem of MDR is serious problem. She states that there are no general 
antibiotic guidelines for the hospital, it depends on every department or it is culture based which 
leads to misuse of the antibiotics. The decisive and final decision in antibiotic prescription is for 
the physician and the role of the pharmacist is only as a consultant if the physicians ask for his/her 
consultancy. She stated that there are initiatives to start a committee to control the antibiotic usage 
which is the stewardship committee but it is still an idea. She do not know what is the GAP 
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initiative; however, she is convinced by the objectives and wants to apply to find a way to control 
this huge problem (Annex 11). 
4.2 Observational study 
The observation was for one week and was divided based on a preplanned schedule (Table 2). 
One day spent in the infection control department, one day in the microbiology laboratory, one 
day in the inpatient pharmacy, 4 days in the wards of different departments to see the 
environment of the nurses and physicians and how they are dealing with the patients.  
The observational study was very useful to study the actual and true environment and analyze 
how people are interacting and dealing with each other. On the first day, there was a visit to 
infection control units at 9 a.m; however, the nurses did not show up except at around 10 
o’clock. The high nurse went for audit on the surgical ward, and what was very distinguishable 
that the audit was for nurses only, not for physicians, there was a physician who was not wearing 
gloves from patient to patient and the infection control nurse only gave a comment to the 
physician very nicely and he did not respond to her. The nurses of the ward were compliant to 
the infection control policies; however, the wards were extremely crowded, there were no spaces 
between beds. The nurses complained that there was no alcohol or gloves and they were 
purchasing gloves out of their pockets, and the infection control nurse responded that the hospital 
has no resources now try to adapt yourself. One of the patients complained that the nurse did not 
change the dressing for 3 days however it was soaked with blood, the infection control nurse 
wrote this to be reported and asked the nurse to change the dressing, but the nurse complained 
that their number is too low to the number of beds in the ward and they need more nurses.  
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On the second day in the microbiology laboratory, the working day which started at 9a.m and 
ended at 1 pm. There were eight technicians and three doctors per day, one of these three doctors 
is a supervisor; thus the working hands are only two physicians responsible for the routine work 
which is around 100 samples each day. During the four working hours, all people were very busy 
working, and responding to the queries of the patients and nurses, which gives a high prediction 
for human error. There were no gloves and the sterilium bottle was empty. They were working 
with their bare hands without gloves. People were touching all surfaces with their hands which 
means they are transmitting infections everywhere. Officially patients are not allowed to enter 
the laboratory; however, they were getting in the lab asking for test results. The workload was 
extremely high for four working hours; moreover, some doctors were required to finish their 
work and then go as a part timer in the infection control department. There was no time to 
communicate with physicians or pharmacists, or to give training for nurses about sampling. 
The pharmacy on the third day was very crowded with pharmacists and nurses. The pharmacy 
opened at 9 a.m, nurses bring the patients’ files with the requests for the antibiotics. Dispensing 
of antibiotics, doses and frequency based on the physician’s request not based on isolation of the 
organism and detecting the true antibiotic sensitivity specific for this organism. The policy is that 
dispensing of antibiotics based on isolation of the causative organism and doing antibiotic 
sensitivity; however, no pharmacist was asking for the culture results and when by asking them 
why the policy is not followed, the response was that they will not postpone the antibiotics for 
patients based on culture and the physicians will never send it; thus the treatment for patients will 
be delayed of no use. Many times, the nurses came asking for antibiotics and were not available, 
again because of the resources are weak or because there is delay from the companies’ supplies. 
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No physicians came to communicate with the pharmacists, only nurses and companies’ 
representatives who came for pharmaceutical marketing.  
The fourth day in the intensive care unit (ICU), the unit had its own policy of antibiotics. Nurses 
and physicians are trained to follow this policy. The head of the ICU is very strict in infection 
control policies and antibiotics policies, he set rules and no one is allowed to break these rules. 
They have plenty of resources which come from donations. The spaces between beds are 
preserved and the nurse bed ratio is maintained. The work for nurses is divided to three shifts 
each is eight hours; however, for physicians there is shortage in number and the shifts are for 36 
hours. The physicians were extremely exhausted and stressed. There are strict regulations of no 
entry except for people working in the ICU; thus, only few hours were allowed to stay there. 
Each nurse is responsible for two patients and taking care of every single item. The infection rate 
in ICU is still high because there are many devices piercing the skin barrier, such as cannulas, 
ventilators, central venous lines etc, and because they are receiving terminal cases from the 
regular wards.  
 The fifth day was in the surgical ward, surgeons from observations are different from all other 
physicians. They are not believing in bacterial infections and the presence of MDR infections, 
and not following the policies of infection control, and they are very resistant to any change. 
They believe that once the surgical operation is successful then their role is done. They do not 
care about infection or bugs that patient can capture before, during or after the surgical operation. 
They are very hard minded and very difficult to be convinced. They need long times of 
negotiations and leadership commitment to be convinced about the presence of microorganisms 
and bacteria. Nurses are more committed than physicians because the infection control audit is 
for nurses and the nurse who is not following polices will receive a punishment. Number of 
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nurses is lower than the normal nurse: patient ratio which is between 1:4 or 1:6, the ratio in the 
surgical ward was around 1:15. There was lack of resources as well. I stayed until 8 p.m; 
however, no one of the surgeons showed up in the ward, it seems that they were spending all the 
day in the operating rooms for surgical operations. There were interns in the ward and they were 
taking care of the patients and can call the resident in any serious situation. The ward was 
crowded and the number of patients was exceeding the capacity of the ward. During 2018, the 
percentage of surgical site infections in the ward was around 5% on average; however, in 
October there was an outbreak in surgical site infections i.e patients with surgical sites after the 
operation were capturing infections in their wounds which lead to failure of the surgery or septic 
infections. The outbreak, which means that many cases were infected by the same MDR 
organism, was discovered by the infection control team in late October, the infection control 
team applied a bundle of actions to control the infection and disinfect the ward. By tracing the 
outbreak back, they discovered that the primary case was a patient admitted from the emergency 
department with stabbed wound in the abdomen. The patient had MDR bacteria and transmitted 
it to patients in the ward either from the patient by contact, or from the physicians who do not 
wear gloves. The outbreak was controlled, and the infection control head notified the head of the 
surgical department officially by the incident, and since then there is some sort of commitment in 
the surgical wards which confirms the same concept that managerial commitment is required to 
change people’s behavior.  
The sixth and seventh days were in the chest, internal medicine and obstetrics and gynecology 
departments.  They were very similar to each other; wards were crowded with patients and their 
relatives. There was no restrictions for visits of relatives. Nurses were trying to implement the 
rules of visiting of relatives but relatives were waiting everywhere.  Beds are beside each other 
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with no enough space to prevent transmission of infection from one patient to another. Patients 
were bringing food and drinks from outside the hospital and hiding them in pillows or blankets, 
so not to be discovered by the nurse. The number of nurses compared to patients is very 
defective which indicated less care for patients. Nurses did not wear gloves because everyone 
should purchase gloves out of their pocket and gloves are expensive. Patients were complaining 
from lack of care and that they may stay for days without antibiotics or routine care from nurses. 
The bed sheets have some old stains on it and look pretty old. There were only four nurses for 
the whole ward with 60 patients. No physicians were seen and when asked about them nurses 
responded that they were in the operating rooms or in the outpatient clinics and will come at 
7pm. They were three residents in the ward. It seems that they were overwhelmed by many tasks 
and duties and this explains why there is no time to communicate with other departments such as 
the Laboratory or to receive trainings for antibiotics or infection control or knowing about WHO 
global plan. At around 6 pm residents started to come to the wards looking exhausted they sat in 
their room looking into the patients’ files. Patients started to leave their beds and come to ask 
them about their queries. They look nervous and told patients in a high-pitched voice to return 
back to their beds and that they will coming to them in the ward. They started their rounds from 
patient to another. They were examining patients without washing their hands or wearing gloves 
due to lack of resources or because they were overwhelmed by tasks. They then finished their 
rounds, returned back to their room, and wrote their observations in patients’ files. 
4.3 Research findings 
It is extremely important to assess whether healthcare personnel are aware of the situation or not 
; thus, a question was introduced at the beginning of the interview to know the percent of their 
awareness about the problem. It returned back that all sectors of healthcare personnel know the 
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problem and aware of its consequences and this was obvious in their responses “Yes, I know 
there is MDR problem and I am convinced that this is a big problem, gram negative organisms 
are the most common”. This quote was received by all the interviewees which gives a clear 
vision that the issue became clear and well known to all. 
However, by probing the question, another finding was detected about the limitedness of 
facilities they have. This was reflected by their response “There is no space for isolation of 
patients” (chest and ICU physicians). Absence of resources or its limitedness was the first 
finding detected and the clearest one; moreover, this finding was expected in all public hospitals 
that depend on governmental funding.  
Digging deep in the interviews to elucidate the behavioral factors, communication factors that 
represent a huge part of the problem. The research discovered that absence of standards and 
guidelines lead to individual decisions based on one’s experience. ”The physician knows that this 
patient is MDR and we isolate the patient” (surgical nurse). “We give him the sensitive antibiotic 
and isolate” (ICU physician). The opposite response that received from two different physicians 
about the way they are dealing with a case of MDR bacteria illustrate that  there are different 
directions in ways of treatment not on definite policies or regulations to face the problem but on 
personal concepts. 
Deeper in the interviews another concepts were discovered, in the core elements that should 
control and prevent resistant bacteria for example, there are no written distributed policies about 
infection control or antibiotic policies; thus, healthcare personnel including physicians lack the 
essential knowledge for proper usage. The response received from physicians was shocking “I 
don’t have a copy of the infection control policies and no one told us about it except few 
times”(chest physician) another physician replied the same  “I do not have antibiotic 
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policies”(internal medicine physician). These results give an overview about the huge problem of 
education and training that healthcare workers suffer from and shed light on the importance of 
studying these root cause taking into consideration the huge effect of these cause on the 
consequences of the problem. By probing the question, another fact was realized that with lack 
of standards, everyone will set his/her own policy which will lead to huge corruption in 
management of the problem. When some physicians were asked about how they treat their 
patients, they responded that “we have an internal policy for antibiotic use (ICU physician). 
Definitely this creates a gap in application of a generalized plan and unified steps to reduce the 
burden of AMR in the hospital settings. 
 In testing the response of healthcare workers on importance of guidelines and standards, the 
response was surprisingly positive and they know that these policies are extremely important to 
prevent the problem. “However, I find infection control is important”(chest physician). These 
findings illustrate the need to have a systematic training, education and standards to facilitate 
medical interaction in the right way and thus decrease the behavioral part of the problem.  
Absence of leadership commitment is another factor that leads to failure of good initiatives. On a 
trial by infection control practitioners to set a surveillances system to monitor the MDR in the 
hospitals; the problem was in the application of the system and this was because of lack of 
support to workers in the system financially and by time and the initiative ended up by being 
inefficient as stated by one of the infection control practioners. “If the surveillance is well 
planned and implemented in the right way with regular follow up it will reduce the rate of 
infection because this is a way of tracing infection. But this is not happening in the right way and 
also it depends on the leadership and commitment” (infection control practitioner). Commenting 
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on this finding, lacking of leadership commitment is another issue which affects the problem in a 
negative way. 
To understand whether the different departments have communication with each other or not, 
questions were introduced in each department to physicians and nurses to understand how 
different departments are communicating to finally reach a decision for the patient. The most 
striking finding was that each unit in the hospital is acting as a separate entity and there is no 
communication between the departments, the lab has no connection with the pharmacy as stated 
by a pharmacist “No we do not have any connections with the Lab” (pharmacist), and physicians 
have no connection with the lab; as stated by a lab physician “We are not consulting the 
physicians” (Lab consultant) and another one “We do not have time and it is difficult to reach 
them”(Lab specialist).  In conclusion, they are not notified about the presence of MDR bacteria 
infecting their patients except after days; consequently, treatment of patients will be delayed or 
mistreated and the problem aggravates. . Another finding discovered from the interviews with 
the Lab specialists that diagnosis of MDR bacteria in the Lab is not considered critical to be 
notified to the physicians immediately and that most of cultures revealed MDR bacteria which 
indicates that it became like an endemic pathogen. The problem of AMR in hospitals and its 
prevalence is mainly seen as a problem of behavior and resources; however, behavior comes first 
and contribute to more than 70% of the problem, such as the misuse of antibiotics, lack of 
communication between the lab and physicians and lack of managerial commitment”. 
Consequently, if we look into the objectives of GAP to estimate to what extent the WHO plan is 
implemented, we will find that the plan and its objectives are met by about 40% if we considered 
that objective 2 and objective 3 are met; however, objective 1,4,5 are not met. 
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Figure 4: Objectives of GAP of WHO (Bhatia, 2018).  
 
4.4 Themes for answering the sub research questions: 
 All sectors of healthcare personnel know the magnitude of the problem and aware of its 
consequences and are afraid from spreading of the risk in the community. This was clear 
in their quotes “Yes, I know there is MDR problem and I am convinced that this is a big 
problem. Ecoli and Klebsiella are the most common”(All physicians). These quotes were 
common among all the interviewees who stated that the risk is very high and the 
causative agents are very aggressive as well. However, due to absence of unified set of 
policies,  each sector is trying to contain the problem from its own perspective and 
depending on the resources they have,  but they do not have the facilities to deal 
efficiently with the problem, and this is clear in the quotes” I manage according to the 
patient clinical situation. If the clinical situation of the patient is ok, the patient stays in 
his place and continue treatment without isolation because we do not have enough 
isolation rooms” (03), this is different from the other physician who stated that “Sure I 
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isolate the MDR patient “(04). These different decisions indicate that lack of standardized 
policies make the decisions subjective.  
 The global action plan of the WHO is not known to anyone, the vice dean for 
environmental and infection control among the healthcare workers was the only one who 
knows about it. There was no announcement about this action plan or the objectives of 
the WHO. This means that the WHO needs to expand and reach all healthcare sectors to 
convey their messages because their messages only reach to certain categories of people 
who are the managers or deputy managers but not go deep to other sectors. The same 
response was received from all healthcare workers when asked about the initiative “I do 
not know about this”(all physicians). Lack of publicity is another major factor in 
spreading the risk because people do not know about the causes of the risk or the actions 
they should take to manage the problem.  
 Healthcare personnel are taking steps to detect and combat the risk. Infection control 
practitioners are making the surveillance to capture the whole picture of MDR and 
monitoring the change in infection rate rapidly “We have the surveillance program 
collected by nurses to enter data of patients in daily audit and monitored daily then 
notify to the infection control doctor. These data is entered by infection control nurses. 
This is a program affiliated to ministry of health and ministry of higher education in 
joint with the Center of Disease and Control (CDC)”. But the final report usually 
missing important data because they are not well trained on the system “if the doctor or 
nurse who is writing the report is knowledgeable, he/she will write important details but 
this is not always happens.” (09, 10) Nurses are following the policies because there is 
continuous audit and monitoring, punishment and praise; but their number is lower than 
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the required nurse to patient ratio; thus, nurses are always drained and exhausted; In 
addition, lack of resources is another burden as seen in the surgical nurse quote “The 
place is very crowded and busy and every patient is sitting in close contact to the other 
patient. There are no isolation rooms only one room in the department” (06). Physicians 
are dealing with patients depending on the situation, and all actions are subjective 
depending of the present physician. They know the problem but lacking standardized 
polices and rules to follow. Their quotes represents their situation “there are many 
problems I cannot do anything with it, such as absence of isolation rooms, the 
crowdedness of patients and the disease can be easily transmitted from one patient to 
another”(05); however, they are doing their maximum effort to contain the risk. 
• There are many impeding factors which act as obstacles in the implementation of 
antimicrobial resistance plan. These includes, the inadequate infrastructure represented 
in the small space, crowdedness of the hospital and absence of isolation rooms. 
Inadequate resources and dependence on donations is another major factor. Insufficient 
number of healthcare workers to number of patients, and the huge workload are 
additional factors which forced people not to follow the standards. 
 
Table3. SWOT analysis 
STRENGHTS 
 
WEAKNESS 
 
• Support from management  
• Experienced personnel 
•  
47 
 
• Awareness of importance of the 
problem 
• Good understanding of actions 
required 
 
• No one knows about the initiative of 
WHO  
• Small group of people driving the 
issue 
• Reliance on individuals rather than 
institutions 
• IC and stewardship are add-ons to 
already high workload 
• Implementation and monitoring  
• Weak communication with physicians 
(esp. in surgical dept.) 
• Training of physicians on IC and 
Stewardship policies. 
• Neglect of workers (cleaners) and 
patients training 
• The role of clinical pharmacists is 
minimized 
 
OPPORTUNITIES THREATS 
 
 
• Established infection control 
structures 
• Increase in the number of patients 
dying from infections rather than 
cancer. 
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• Growing nat. and intl. attention to 
AMR 
- Exchange 
- Funding  
• Strong reputation of the hospital.  
 
• Competitive public and private 
hospitals 
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Chapter Five: Conclusions and Recommendations 
5.1 Conclusion:    
          What concluded from the study that barriers against implementation of AMR plan differ in 
developing countries from developed ones, the causes in developing countries are much complex 
because it depends on behavioral factors in addition to financial and resource limited factors. 
However, the behavioral factor is playing a major role in these countries and can be fixed by 
setting the rules and have a strong leadership. 
Absence of strong leadership commitment which is required to set and maintain the rules leads to 
loose or absent application of initiatives such as the surveillance which was not implemented 
efficiently as it was supposed to be effective in containing the problem of AMR. 
Lack of standardized policies and regulations for the usage of antibiotics in treatment and 
policies of infection control and absence of programmed training for residents and nurses about 
infection control opens the door for subjective decisions for using certain types of antibiotics, or 
applying different standards. 
Lastly, lack of communication between different departments is another major challenge because 
each department acts autonomously and is seeing the problem from its own side. People are 
aware of the magnitude of the problem; however, do not know how to manage it with the current 
and available resources. There is low publicity about the WHO GAP; however, healthcare 
workers are aware by the objectives. People are welcoming any initiative from international 
organizations as long as these organizations are trusted, such as Center of Disease and Control 
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CDC and World Health Organization WHO, but the major concern is about sustainability which 
needs a lot of money and leadership commitment and these are lacking currently.  
5.2 Recommendations: 
After analysis of the study a set of recommendations is developed which could help to contain 
the problem; 
The better use of human resources, it is important to use these human resources in a right way. 
Part time jobs and multitasking are not good options. Jobs should be full-time which enables 
personnel to work efficiently. Setting adequate ratio between nurses and patients, physicians and 
patients and not overloading the staff is another important factor. 
Authority should be given for pharmacists who are more knowledgeable than physicians in 
antibiotics, their interactions and their side-effects. This should be a decision of the upper 
management, implemented and followed by pharmacists. Clinical pharmacy is a well-established 
branch in USA and Europe countries; however, countries like Egypt still there is strong 
domination for physicians which will has bad consequences on antimicrobial resistance.  
Communication with different healthcare personnel is mandatory. Physicians should be 
communicating with pharmacists and laboratory physicians for better interpretation of results. 
Communication will also lead to rapid detection of multidrug resistant cases, rapid management 
and isolation to prevent transfer to others. Communication system is present in hospitals of USA 
and Europe; however, in Egypt it is not settled yet except in some private hospitals. 
Hospitals should hire full-time consultants for infection prevention and control and stewardship. 
These specialties should not be add-ons to already high workload. There should be time to set 
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plans, implement and monitor, then receiving the feedback to improve again. Part-time jobs with 
high workload is a mess and people wont be focused on their targets. 
Systematic training on infection control policies and stewardship should be given to physicians 
at the beginning of their residency in the orientation program; thus, they will be exposed to these 
concepts before touching patients. These programs need the commitment and support of the 
higher management. Moreover, intensive training and follow up should be given to cleaning 
workers who are dangerous source of transmitting infections through mops, door knobs and light 
switches. 
Big public hospitals should use their strong reputation and great history to make collaboration 
with international organizations for capacity building and funding opportunities, so there will be 
mutual benefits and experience exchange between the two organizations. 
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ANNEXES 
Annex 1 
1-Do you see ABR as a big problem  
3-Are there any guidelines for infection control policies? 
4-Who wrote the policy? 
5-How is the implementation of guidelines of infection control implemented and monitored? E.g 
hand hygiene? 
6-How do you improve compliance of people? 
7-Are there any guidelines on collecting and analyzing (surveillance) data of resistant strains?  
8-Who coordinates ABR surveillance, (The microbiology lab or the infection control unit? 
10- What information does the report contain and report to whom? 
11-How much ABR surveillance reduce the ABR problem? 
12- Which organisms pose the greatest problem? What information is the answer based on? 
13-Do you have XDR or PDR pathogens reported? 
13- How many infection control nurses and physicians you have, full time of part time?  
14-What are the measures done for wards with higher infection rates to reduce the infection? 
Politically with heads and physicians if not cooperate. 
15- What do you see as the greatest drivers of ABR? 
16-Is there an intranet to share data within the hospital? Do you share data outside the hospital? 
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17-From your opinion what could be done to improve ABR? 
1. In your experience, how are international AMR initiatives perceived by the Egyptians?  
2.  “Sustainability”, how can we reach it for AMR when international organisations stop 
funding these programs? 
3. How do you find the WHO global action plan to combat AMR? 
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Annex 2 
1. To start off, I would like to ask you to briefly describe your current role and the main 
areas of your work?  
2. Which organisations does WHO collaborate with to strengthen AMR surveillance in 
Egypt?  
3. What are the main challenges for strengthening AMR surveillance in Egypt? 
4. In your experience, is the sharing of data problematic in Egypt? If so, what are the 
greatest hurdles?  
5. Does WHO have political support for AMR surveillance in Egypt? What convinces 
policy makers to start surveillance on AMR? 
6. What is the difference between the work of the US CDC on AMR surveillance in Egypt 
and the work undertaken through WHO? Is there coordination between both 
organizations?  
7. In your experience, how are international AMR initiatives perceived by the Egyptian 
government?  
8. “Sustainability”, how can we reach it for AMR when international organisations stop 
funding these programs? 
9. There is a National Action Plan under way in Egypt. Do you know who is involved in 
working on this Plan, and what the main priorities are?  
10. How does WHO deal with the complicated health care structure in Egypt e.g hospitals are 
under the umbrella of different ministries, and the role of private hospitals? Does WHO 
consult and interact with all these different players in the healthcare system? 
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Annex 3 
1-Do you see Antimicrobial resistance (AMR) as a big problem at your hospital? What is the 
percent? 
2-Are there antibiotic policies you follow?  
3-How do you find Infection control policies? 
4-How do you find the WHO global action plan to combat AMR? 
5-What are actions you take to prevent transmission of AMR? 
6-What kinds of problems are you facing in your work which could hinder the application of 
AMR GAP? 
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Annex 4 
1-Do you see Antimicrobial resistance (AMR) as a big problem at your hospital? What is the 
percent? 
2-Are there antibiotic policies you follow?  
3-How do you find Infection control policies? 
4-How do you find the WHO global action plan to combat AMR? 
5-What are actions you take to prevent transmission of AMR? 
6-What kinds of problems are you facing in your work which could hinder the application of 
AMR GAP? 
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Annex 5 
1-Do you see Antimicrobial resistance (AMR) as a big problem at your hospital? What is the 
percent? 
2-Are there antibiotic policies you follow?  
3-How do you find Infection control policies? 
4-How do you find the WHO global action plan to combat AMR? 
5-What are actions you take to prevent transmission of AMR? 
6-What kinds of problems are you facing in your work which could hinder the application of 
AMR GAP? 
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Annex 6 
1-Do you see ABR as a big problem  
3-Are there any guidelines for infection control policies? 
4-Who wrote the policy? 
5-How is the implementation of guidelines of infection control implemented and monitored? E.g 
hand hygiene? 
6-How do you improve compliance of people? 
7-Are there any guidelines on collecting and analyzing (surveillance) data of resistant strains? 
When, why, type? 
8-Who coordinates ABR surveillance, (The microbiology lab or the infection control unit? 
10- What information does the report contain and report to whom? 
11-How much ABR surveillance reduce the ABR problem? 
12- Which organisms pose the greatest problem? What information is the answer based on? 
13-Do you have XDR or PDR pathogens reported? 
14-What are the measures done for wards with higher infection rates to reduce the infection? 
15- What do you see as the greatest drivers of ABR? 
16-Is there an intranet to share data within the hospital? Do you share data outside the hospital? 
17-From your opinion what could be done to improve ABR? 
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Annex 7 
1-Do you see ABR as a big problem  
3-Are there any guidelines for infection control policies? 
4-Who wrote the policy? 
5-How is the implementation of guidelines of infection control implemented and monitored? E.g 
hand hygiene? 
6-How do you improve compliance of people? 
7-Are there any guidelines on collecting and analyzing (surveillance) data of resistant strains? 
When, why, type? 
8-Who coordinates ABR surveillance, (The microbiology lab or the infection control unit? 
10- What information does the report contain and report to whom? 
11-How much ABR surveillance reduce the ABR problem? 
12- Which organisms pose the greatest problem? What information is the answer based on? 
13-Do you have XDR or PDR pathogens reported? 
14-What are the measures done for wards with higher infection rates to reduce the infection? 
15- What do you see as the greatest drivers of ABR? 
16-Is there an intranet to share data within the hospital? Do you share data outside the hospital? 
17-From your opinion what could be done to improve ABR? 
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Annex 8 
1-Do you see ABR as a big problem? 
2-Which organisms pose the greatest problem? What experiences, information is the answer 
based on? 
3-Is the lab going through a proficiency testing by external agency for sample analysis and 
interpretation? 
4- Do you contact the pharmacy to be sure that the drugs tested are available at the pharmacy? 
5-How are the results recorded and reported to the ward? 
6-Do you give a pre-analytical awareness for the nurses and physicians for sampling and 
transport of samples? 
7-How often do you consult a physician on managing a serious infection? 
8-Do you notify physicians directly if you have MDR diagnosed? 
9-Do you have XDR and PDR? 
10-What are the wards show highest infection rates with MDR? 
11-What do you see as the greatest drivers of ABR? 
12-From your opinion what the lab could do to improve the ABR problem? 
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Annex 9 
1-Do you see ABR as a big problem? 
2-Which organisms pose the greatest problem? What experiences, information is the answer 
based on? 
3-Is the lab going through a proficiency testing by external agency for sample analysis and 
interpretation? 
4- Do you contact the pharmacy to be sure that the drugs tested are available at the pharmacy? 
5-How are the results recorded and reported to the ward? 
6-Do you give a pre-analytical awareness for the nurses and physicians for sampling and 
transport of samples? 
7-How often do you consult a physician on managing a serious infection? 
8-Do you notify physicians directly if you have MDR diagnosed? 
9-Do you have XDR and PDR? 
10-What are the wards show highest infection rates with MDR? 
11-What do you see as the greatest drivers of ABR? 
12-From your opinion what the lab could do to improve the ABR problem? 
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Annex 10 
1-Do you see ABR as a big problem? 
2- Is there any guidelines regulate antibiotic use, prescription for treatment? 
3-Who have the decisive role in controlling antibiotic usage,? 
5-What do you see as the greatest drivers of ABR? 
6-What aspects of prescribing practices may contribute to ABR? 
7-Does the pharmacy report on the consumption of antibiotics? 
8-Has application of ABR surveillance, infection control and antibiotic policy affected the 
antibiotic consumption? 
9-From your opinion what the pharmacy can do to improve the ABR problem (Dose, duration, 
cycling) 
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Annex 11 
1-Do you see Antimicrobial resistance (AMR) as a big problem at your hospital? What is the 
percent? 
2-How do you find Infection control policies? 
3-What are actions you take to prevent transmission of AMR? 
4-What kinds of problems are you facing in your work which could hinder the application of 
AMR GAP? 
 
  
 
